Evidence map›Paper›PMID 15314166›Full record

ArticleMolecular and cellular biology2004

Separation of insulin signaling into distinct GLUT4 translocation and activation steps.

Makoto Funaki, Paramjeet Randhawa, Paul A Janmey

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 65 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Makoto FunakiDepartment of Physiology, Institute for Medicine and Engineering, University of Pennsylvania, 1080 Vagelos Research Laboratories, 3340 Smith Walk, Philadelphia, PA 19104, USA. funaki@mail.med.upenn.edu
Paramjeet Randhawa
Paul A Janmey
University of Pennsylvania · US

Funding

REVERSIBLE FORMATION AND STRUCTURE OF ACTIN NETWORKSR01AR038910 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI JANMEY, PAUL A · 1991 to 2006
$2.2M
REVERSIBLE FORMATION AND STRUCTURE OF ACTIN NETWORKSR29AR038910 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI JANMEY, PAUL A · 1987 to 1989
–
NIAMS NIH HHS AR38910NIAMS NIH HHS R01 AR038910
6 · The paper itself

Abstract

GLUT4 (glucose transporter 4) plays a pivotal role in insulin-induced glucose uptake to maintain normal blood glucose levels. Here, we report that a cell-permeable phosphoinositide-binding peptide induced GLUT4 translocation to the plasma membrane without inhibiting IRAP (insulin-responsive aminopeptidase) endocytosis. However, unlike insulin treatment, the peptide treatment did not increase glucose uptake in 3T3-L1 adipocytes, indicating that GLUT4 translocation and activation are separate events. GLUT4 activation can occur at the plasma membrane, since insulin was able to increase glucose uptake with a shorter time lag when inactive GLUT4 was first translocated to the plasma membrane by pretreating the cells with this peptide. Inhibition of phosphatidylinositol (PI) 3-kinase activity failed to inhibit GLUT4 translocation by the peptide but did inhibit glucose uptake when insulin was added following peptide treatment. Insulin, but not the peptide, stimulated GLUT1 translocation. Surprisingly, the peptide pretreatment inhibited insulin-induced GLUT1 translocation, suggesting that the peptide treatment has both a stimulatory effect on GLUT4 translocation and an inhibitory effect on insulin-induced GLUT1 translocation. These results suggest that GLUT4 requires translocation to the plasma membrane, as well as activation at the plasma membrane, to initiate glucose uptake, and both of these steps normally require PI 3-kinase activation.

Indexed as

Muscle Proteins3T3 CellsAdipocytesAminopeptidasesAnimalsCell MembraneCystinyl AminopeptidaseEndocytosisEnzyme ActivationFluorescent DyesGlucoseGlucose Transporter Type 4HumansInsulinMiceMonosaccharide Transport ProteinsAminopeptidasesCystinyl AminopeptidaseFluorescent DyesGlucoseGlucose Transporter Type 4Insulinleucyl-cystinyl aminopeptidaseMonosaccharide Transport ProteinsMuscle ProteinsPeptidesPhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsProtein Serine-Threonine KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-aktSLC2A4 protein, humanSlc2a4 protein, mouse

Identifiers

PMID15314166
PMCPMC507006
OpenAlexW2156589968

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.